Royal Hospital for Women trial celebrates first pregnancy

“It’s come at the earliest time I would have expected to have had a positive outcome,” Deans said. “I couldn’t be happier.”

Bryant’s mother and donor, Michelle Hayton, said the prospect of having a fifth grandchild – grown in the same womb as her own two children – made the 11-hour surgery and lengthy recovery worth it.

“To think that I gave her my uterus in January, and we could have a baby in December … I’m over the moon,” Hayton said. “This is the one thing that we wanted or hoped from the procedure.”

Although a significant milestone, Bryant and her family know there is still a long way to go. Her pregnancy is high-risk; the prescription medications ensuring she doesn’t reject the transplant have suppressed her immune system, and she won’t be able to feel contractions or movements in her uterus because it isn’t connected to her nervous system.

She will be monitored with an ultrasound every two weeks before undergoing a scheduled caesarean section at 37 weeks.

Uterus transplants are temporary and last around five years. The aim is to give women enough time to have children, but minimise the long-term side effects of immunosuppressants required after other organ transplants.

Loading

More than 70 uterus transplants have so far been performed worldwide, resulting in around 35 live births.

Deans is planning a second embryo transfer, and aims to provide transplants to a further four women during the first trial phase.

The trial is funded through the Royal Hospital for Women Foundation, and Deans hopes to secure further funding to perform transplants on another six women.

She said the trial was intended to expand the fertility options available to women in Australia.

“For many women, the thought of being able to carry their own child is a massive thing,” she said. “It’s amazing that we can actually offer it.”

The Morning Edition newsletter is our guide to the day’s most important and interesting stories, analysis and insights. Sign up here.